1. |
World Health Organization. The online globocan 2020 database. (2021-02-28)[2021-05-12].https://www.iarc.who.int/faq/latest-global-cancer-data-2020-qa/.
|
2. |
Xu TT, Wu J. Financial toxicity of cancer in China. J Cancer Policy, 2018, 15(7): 96-99.
|
3. |
Krieger N, Bassett MT, Gomez SL. Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet, 2012, 379(9824): 1391-1392.
|
4. |
Xia J, Tang Z, Deng Q, et al. Predictors of the quality of life in Chinese breast cancer survivors. Breast Cancer Res Treat, 2018, 167(2): 537-545.
|
5. |
Zafar SY, Abernethy AP. Financial toxicity, Part Ⅱ: how can we help with the burden of treatment-related costs?. Oncology (Williston Park), 2013, 27(4): 253-254, 256.
|
6. |
易琼, 田勇梅, 黄岑, 等. 综合性医院日间化疗病房医护一体化管理模式探索与实践. 中国护理管理, 2014, 14(10): 1095-1098.
|
7. |
张继东, 闻大翔, 骆华杰, 等. 日间医疗的实践探索与思考. 中华医院管理杂志, 2017, 33(5): 345-348.
|
8. |
Dimitrova M, Gilchrist M, Seaton RA. Outpatient Parenteral Antimicrobial Therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. BMJ Open, 2021, 11(9): e49733.
|
9. |
李晨雄, 王丹, 莫陶欣, 等. 国内日间化疗工作开展现况调查研究. 中国医院管理, 2022, 42(2): 47-49.
|
10. |
廖藏宜, 蔡文富, 李峰, 等. 门诊按人头打包付费的台州经验及改革成效. 卫生经济研究, 2021, 38(12): 47-50.
|
11. |
吴荣海, 向前. 基本医疗保险按病种分值付费比较研究. 经济师, 2021(1): 240, 242.
|
12. |
倪平, 陈京立, 刘娜. 护理研究中量性研究的样本量估计. 中华护理杂志, 2010, 45(4): 378-380.
|
13. |
de Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer, 2014, 120(20): 3245-3253.
|
14. |
于慧会, 毕雪, 刘运泳. 中文版癌症患者报告结局的经济毒性量表信度和效度研究. 中华流行病学杂志, 2017, 38(8): 1118-1120.
|
15. |
袁潇逸, 孙艳玲, 况艺, 等. 乳腺癌生存者经济毒性现状及其对生活质量的影响研究. 护士进修杂志, 2022, 37(23): 2113-2118.
|
16. |
孙艳玲, 况艺, 袁潇逸, 等. 癌症生存者经济毒性现状及影响因素. 护理学杂志, 2022, 37(15): 24-27, 31.
|
17. |
Chan RJ, Gordon LG, Tan CJ, et al. Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review. J Pain Symptom Manage, 2019, 57(3): 646-660.e1.
|
18. |
Jing J, Feng R, Zhang X, et al. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China. Breast Cancer Res Treat, 2020, 181(2): 435-443.
|
19. |
Moore AM, Gamblin TC, Geller DA, et al. A prospective study of posttraumatic growth as assessed by self-report and family caregiver in the context of advanced cancer. Psychooncology, 2011, 20(5): 479-487.
|
20. |
Honda K, Gyawali B, Ando M, et al. Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in Japanese patients with cancer. J Glob Oncol, 2019, 5: 1-8.
|
21. |
Blinder V, Eberle C, Patil S, et al. Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Aff (Millwood), 2017, 36(2): 274-281.
|
22. |
Zhu Z, Xing W, Zhang X, et al. Cancer survivors' experiences with financial toxicity: a systematic review and meta-synthesis of qualitative studies. Psychooncology, 2020, 29(6): 945-959.
|
23. |
Pauge S, Surmann B, Mehlis K, et al. Patient-reported financial distress in cancer: a systematic review of risk factors in universal healthcare systems. Cancers (Basel), 2021, 13(19): 5015.
|
24. |
周德水, 党思琪. 商业健康保险对居民健康的影响—来自 CGSS 数据的经验证据. 中国卫生政策研究, 2021, 14(8): 8-15.
|
25. |
Thom B, Benedict C, Friedman DN, et al. The intersection of financial toxicity and family building in young adult cancer survivors. Cancer, 2018, 124(16): 3284-3289.
|
26. |
Gordon LG, Merollini KMD, Lowe A, et al. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient, 2017, 10(3): 295-309.
|
27. |
Su TT, Azzani M, Tan FL, et al. Breast cancer survivors: return to work and wage loss in selected hospitals in Malaysia. Support Care Cancer, 2018, 26(5): 1617-1624.
|
28. |
Huang HY, Shi JF, Guo LW, et al. Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study. LANCET, 2016, 388(Suppl 1): S10.
|
29. |
何伟丽, 练会招, 翟贺宁, 等. 乳腺癌患者新辅助化疗效果. 中国老年学杂志, 2022, 42(7): 1598-1601.
|
30. |
景静凤. 非转移性乳腺癌患者经济毒性调查及影响因素分析. 太原: 山西医科大学, 2020.
|